(EXAS) EXACT Sciences - Performance 26.4% in 12m
EXAS performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-43.93%
#60 in Peer-Group
Rel. Strength
73.12%
#1997 in Stock-Universe
Total Return 12m
26.44%
#43 in Peer-Group
Total Return 5y
-37.63%
#49 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 2.50K |
| High / Low | USD |
|---|---|
| 52 Week High | 71.93 USD |
| 52 Week Low | 40.31 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 51.46 |
| Buy/Sell Signal +-5 | 1.82 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: EXAS (26.4%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
0.31% | 66.4% | 81.3% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-11.3% | -10.9% | 137% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-2.26% | -8.02% | 39.9% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
2.47% | 33.7% | 4.38% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
12.2% | 64.2% | 3.4% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
1.42% | -10.5% | -0.06% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| PTCT NASDAQ PTC Therapeutics |
1.94% | 59.9% | -1.58% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.88% | 35.5% | 16% | 28.9 | 15.1 | 0.63 | -62.1% | -19.3% |
Performance Comparison: EXAS vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for EXAS
| Total Return (including Dividends) | EXAS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -6.89% | 3.18% | 4.52% |
| 3 Months | 23.93% | 2.36% | 10.25% |
| 12 Months | 26.44% | -10.75% | 14.16% |
| 5 Years | -37.63% | -24.51% | 116.91% |
| Trend Score (consistency of price movement) | EXAS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -86.7% | 30.9% | 79.1% |
| 3 Months | 67.9% | 63.2% | 91.7% |
| 12 Months | -31.7% | -83.8% | 44% |
| 5 Years | -65.2% | -52.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th33.50 | -9.76% | -10.92% |
| 3 Month | %th76.00 | 21.07% | 12.41% |
| 12 Month | %th79.50 | 41.68% | 10.76% |
| 5 Years | %th76.50 | -17.38% | -71.25% |
FAQs
Does EXACT Sciences (EXAS) outperform the market?
Yes,
over the last 12 months EXAS made 26.44%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.75%.
Over the last 3 months EXAS made 23.93%, while XBI made 2.36%.
Performance Comparison EXAS vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
EXAS vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.4% | -11.4% | -9.7% | 12% |
| US NASDAQ 100 | QQQ | -1% | -12.4% | -11.1% | 12% |
| German DAX 40 | DAX | -1.2% | -7.3% | -24.9% | -4% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.3% | -9.4% | -5.7% | 10% |
| Hongkong Hang Seng | HSI | -0.7% | -13.7% | -26.9% | -9% |
| India NIFTY 50 | INDA | -0.7% | -9.2% | -10.6% | 26% |
| Brasil Bovespa | EWZ | 0.4% | -10.4% | -31.3% | 16% |
EXAS vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -1.5% | -13.8% | -16% | -1% |
| Consumer Discretionary | XLY | 0.2% | -8.8% | -1.7% | 6% |
| Consumer Staples | XLP | 3.2% | -5.7% | -8.6% | 18% |
| Energy | XLE | 3% | -11.4% | -7.1% | 30% |
| Financial | XLF | -0.1% | -9.4% | -12.9% | -2% |
| Health Care | XLV | 0.8% | -8.6% | -3% | 32% |
| Industrial | XLI | 0.1% | -10.1% | -16.5% | 3% |
| Materials | XLB | 1% | -9.2% | -10.5% | 23% |
| Real Estate | XLRE | 4.3% | -6.4% | -8% | 15% |
| Technology | XLK | -1.1% | -15.3% | -11.9% | 16% |
| Utilities | XLU | 2% | -7.9% | -13.4% | 3% |
| Aerospace & Defense | XAR | -2.2% | -16.5% | -30.8% | -25% |
| Biotech | XBI | 1.2% | -10.1% | 3.1% | 37% |
| Homebuilder | XHB | 1% | -10.8% | 0.8% | 26% |
| Retail | XRT | 1.9% | -9% | -2.3% | 20% |
EXAS vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 6.2% | -16.0% | -2.48% | 37% |
| Natural Gas | UNG | 3.9% | -10.3% | 3.7% | 27% |
| Gold | GLD | 5.3% | -5.5% | -29.7% | -13% |
| Silver | SLV | 3.1% | -14.6% | -28% | 5% |
| Copper | CPER | -1.2% | -15.5% | -28.1% | 11% |
EXAS vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 1.4% | -8.7% | -5.9% | 25% |
| iShares High Yield Corp. Bond | HYG | 1.6% | -8.4% | -9.2% | 16% |